Citigroup
EIKN

Citigroup’s Eikon Therapeutics EIKN Stock Holding History

Citigroup’s Portfolio EIKN Stock Details EIKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Buy
+16,779
New +$171K ﹤0.01% 4296

Other funds holding EIKN

TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
AP
Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Citigroup's EIKN Position: Q2 2026 in Review

Citigroup opened a new position in Eikon Therapeutics (EIKN) in Q2 2026: 16,779 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #4296 among its holdings.

12 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.

  • Citigroup held 16,779 shares of Eikon Therapeutics worth $219K as of Q2 2026.
  • Eikon Therapeutics was a new Citigroup position in Q2 2026.
  • Eikon Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4296 holding.
  • 12 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.